Immunotherapy: Beneficial loss

Abstract

Atm http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?db=gene&c md=Retrieve&dopt=full_ report&list_uids=11920 Cytotoxic T lymphocytes (CTLs) mediate the host immune response against immunogenic tumours but, unfortunately, several hurdles limit their effective use as a cancer immunotherapy. For example, to be fully activated T cells require — besides T-cell… (More)
DOI: 10.1038/nrc2143

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.